Filing
1st Quarter - Report
Lobbying activity
2
Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to tobacco harm reduction. Discussions related to FDA Premarket Tobacco Product Applications (PMTAs). Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to the FY2027 appropriations process.
Discussions concerning federal funding related to the Centers for Disease Control and Prevention.